In this article
Key takeaways
- Ablation and embolisation are image-guided treatments carried out by interventional radiologists as part of care for some liver tumours.
- Treatment plans are decided by a multidisciplinary team, taking into account the tumour's size, position and spread, how well the liver works and your general health.
- Thermal ablation uses heat, delivered through a needle guided by ultrasound or CT, to destroy small tumours, often when surgery is not suitable.
- Embolisation treatments (TAE and TACE) reduce the blood supply to a tumour through a catheter in the liver artery; SIRT delivers internal radiation by a similar route.
- A flu-like reaction, tiredness and some abdominal discomfort are common in the days after these procedures; your team will advise on what to report.
- Each treatment has a specific aim, which may be to treat, to control growth or to ease symptoms, and your team will explain the aim in your case.
When a tumour is found in the liver, people often hear unfamiliar terms such as ablation, chemoembolisation or SIRT. These are image-guided treatments, carried out by interventional radiologists, that can form part of the care plan for some liver tumours. They are not suitable for everyone, and they are rarely the whole story: decisions are made by a team of specialists who look at the full picture. This guide explains what these treatments involve, how they fit alongside other options and what the days after treatment can be like, so that you can take part in conversations with your care team with more confidence.
How treatment decisions are made
Liver tumours vary widely. A tumour may start in the liver itself, which is called primary liver cancer, or it may have spread to the liver from another part of the body, which is called secondary liver cancer. Care for secondary liver cancer depends a great deal on where the cancer began, so the information here relates mainly to tumours that start in the liver.
In most hospitals, treatment is planned by a multidisciplinary team (MDT). This usually includes liver specialists, surgeons, cancer doctors and radiologists, among others. The team considers:
- the size and number of tumours and where they sit in the liver;
- whether the cancer has spread, including into blood vessels or beyond the liver;
- the type of tumour;
- how well the liver is working, which matters particularly if there is underlying liver disease such as cirrhosis;
- your general health and fitness, and your own wishes.
A member of the team will then talk you through the options, including what each treatment aims to achieve and its possible side effects. It is entirely reasonable to ask questions, take time to think, or bring someone with you to these conversations.
The range of treatments for liver tumours
Image-guided treatments sit alongside several other approaches. Depending on the situation, the team may discuss:
- Surgery to remove part of the liver, or a liver transplant in selected cases;
- Thermal ablation to destroy small tumours with heat;
- Embolisation, including TAE and TACE, to reduce a tumour's blood supply;
- Selective internal radiation therapy (SIRT), which delivers radiation from inside the liver's blood vessels;
- Targeted medicines and immunotherapy, which work throughout the body;
- Radiotherapy from outside the body;
- Monitoring of very small areas found during surveillance, and supportive care focused on comfort and quality of life.
Clinical trials may also be an option for some people, and your team can tell you whether any are relevant.
Thermal ablation
Thermal ablation uses heat to destroy tumour cells. The two main types are radiofrequency ablation, which uses electrical energy, and microwave ablation, which uses microwave energy. Other ablation methods, such as freezing (cryoablation) or injecting alcohol into the tumour, are used in some centres.
When ablation may be considered
Ablation is generally used for small tumours. It may be considered when surgery is not suitable, for example because of a tumour's position close to a major blood vessel, or because a person is not well enough for an operation. For some very small tumours it may be discussed as an alternative to surgery. It can also be used to control a tumour while someone waits for a liver transplant. It is not usually suitable for larger tumours or when the cancer has spread beyond the liver.
What happens during ablation
Before treatment there is a pre-assessment, usually with blood tests and a heart tracing (ECG). You may need to pause certain blood-thinning medicines, but only on medical advice, and you will be asked not to eat for some hours beforehand.
The procedure is carried out by an interventional radiologist, supported by radiographers and nurses. It is done under a general anaesthetic or under sedation with local anaesthetic and pain relief. Using ultrasound or CT images, the radiologist guides a needle through the skin into the tumour, and energy delivered through the needle heats and destroys the tumour cells. Treatment takes from around half an hour to a couple of hours.
Most people stay in hospital overnight, and many return to their usual activities after about a week. A scan is usually arranged some weeks later to see how the area has responded.
Embolisation: TAE and TACE
Embolisation reduces or blocks the blood supply to a tumour. It relies on a feature of the liver's circulation: healthy liver tissue receives much of its blood from the portal vein, whereas liver tumours depend mainly on the hepatic artery. Blocking the branches that feed the tumour can therefore deprive it of blood while the rest of the liver continues to be supplied.
- Transarterial embolisation (TAE) uses a blocking material, such as a gel or tiny beads.
- Transarterial chemoembolisation (TACE) delivers chemotherapy into the vessels supplying the tumour before they are blocked, either directly or loaded onto beads that release it slowly. Most of the treatment stays close to the tumour.
When embolisation may be considered
Embolisation is generally used for primary liver cancer when surgery or ablation is not possible and the cancer has not spread beyond the liver. It is not intended to remove the cancer completely. Its aims are usually to control growth and relieve symptoms. In some people it is used to shrink a tumour so that surgery becomes possible, or to control the cancer while waiting for a transplant. Good liver and kidney function are generally needed.
What happens during embolisation
The procedure takes place in the X-ray department and usually lasts one to two hours. An interventional radiologist passes a thin catheter through an artery in the groin and, using contrast dye and X-ray images, guides it into the hepatic artery and then into the branches feeding the tumour, where the treatment is released. Afterwards you will lie flat for a few hours. Many people stay in hospital for one or two nights, and the treatment may be repeated if the team feels it would help.
Selective internal radiation therapy
SIRT also works through the liver's blood supply. Instead of blocking the vessels, tiny radioactive beads are delivered into the arteries feeding the tumour, so that radiation is given from inside the liver. It may be considered for adults whose cancer cannot be removed with surgery and whose liver function is reasonably well preserved. The assessment and planning for SIRT usually involve additional scans.
Side effects and recovery
After ablation or embolisation, many people develop a flu-like reaction, often called post-ablation or post-embolisation syndrome. It typically begins a few days after treatment, with aches, a raised temperature, nausea and tiredness, and can last one to two weeks. Other common effects include:
- pain or discomfort in the upper right side of the abdomen, or sometimes in the shoulder;
- bruising at the needle or catheter site;
- tiredness lasting a couple of weeks.
Less common risks include infection, bleeding, injury to nearby structures such as the bile ducts or bowel, damage to a blood vessel, kidney problems, and an allergic reaction to contrast dye. Very rarely, the liver's function can worsen. With TACE, some chemotherapy can enter the bloodstream and temporarily affect blood counts.
Contact your care team promptly if pain becomes worse rather than better, or if you develop a high temperature after going home.
Follow-up and ongoing care
Follow-up scans and blood tests help the team understand how a tumour has responded and whether further treatment, including a repeat procedure, might be helpful. Sometimes treated areas do not respond completely, or new areas appear, and the plan is adjusted. Support from specialist nurses and, where appropriate, palliative care teams focused on comfort and symptom control can be part of care at any stage.
Next steps
If you or a family member are facing decisions about a liver tumour, an interventional radiologist can explain whether image-guided treatment may have a role, working alongside the wider specialist team that plans your care. Learn more about our interventional radiology specialists, or use our matching tool to Find my physician to arrange a consultation or a review of your existing scans.
Frequently asked questions
These decisions are made by a multidisciplinary team that usually includes liver specialists, surgeons, cancer doctors and radiologists. They review your scans, blood tests and overall health, and a member of the team then explains the options with you.
No incision is usually needed. A needle is passed through the skin into the tumour using ultrasound or CT guidance, under general anaesthetic or sedation with local anaesthetic, and heat is used to destroy the tumour cells.
Both treatments block the arteries that feed a liver tumour. In TAE only a blocking material is used. In TACE, chemotherapy is delivered into the vessels supplying the tumour before they are blocked, so that most of it stays close to the tumour.
Healthy liver tissue receives much of its blood from the portal vein, while liver tumours depend mainly on the hepatic artery. This allows the tumour's supply to be reduced while the rest of the liver continues to receive blood.
Many people have a flu-like reaction a few days after ablation or embolisation, with aches, a raised temperature and tiredness, which can last a week or two. Some have discomfort in the upper right side of the abdomen or shoulder. Contact your team if pain worsens or you develop a high temperature.
Sometimes. Embolisation may be repeated, and an area treated with ablation can sometimes be treated again if needed. Follow-up scans help your team plan any further care.
In some situations, ablation or embolisation is used to control a tumour while a person is on the waiting list for a transplant. Your transplant and cancer team will advise whether this applies to you.
References
- Treatment options for liver cancer(opens in a new tab)Cancer Research UK · Accessed November 2, 2026
- Heat treatment for liver cancer (thermal ablation)(opens in a new tab)Cancer Research UK · Accessed November 2, 2026
- Embolisation treatment for liver cancer (TAE or TACE)(opens in a new tab)Cancer Research UK · Accessed November 2, 2026
- Treatment for liver cancer(opens in a new tab)NHS · Accessed November 2, 2026
- Liver Cancer Treatment (PDQ) - Patient Version(opens in a new tab)National Cancer Institute · Accessed November 2, 2026
- Secondary liver cancer(opens in a new tab)Cancer Research UK · Accessed November 2, 2026
This article is for general information and is not medical advice. Diagnosis and treatment decisions are made by a physician at an authorized healthcare facility.